| |
Technology
 |
|
Avanti’s Smart Detection Technology platform offers a unique
approach to miniaturizing and integrating life science
applications. Innovative nanoparticle based technology will
enable to generate more information from less sample,
improving both productivity and efficiency in
biopharmaceutical product life cycle. Using a proprietary
NanoBindi technology platform, the many steps of
conventional applications are eliminated &/or streamlined
into single, nanoliter scale procedures. NanoBindis are
proprietary nanoparticles with core-shell architecture. The
particles contain a brightly fluorescent core with a silica
shell. Avanti NanoScience Molecular workbench, in the form
of a NanoArray disk, contains hundreds of identical
application-specific array dots where samples are processed
in parallel, under the control of GateKeeper ID Workstation.
Avanti NanoSciences’ technology delivers cost-effective,
fast, accurate and reproducible results using less sample
and no reagents and with minimal user intervention. |
 |
Reduced cost and labor by multiplexing |
|
|
Shortened time-to-results by favorable reaction kinetics of
liquid particle array approach, with smaller sample requirements |
|
|
Enhamced reaction kinetics give faster, more reproducible
results than with solid, planar arrays |
|
|
Focused, flexible multiplexing in the range of 1 to 1000 analytes
with multiparameter testing meets the needs of a wide variety of applications -
protein expression profiling, focused gene expression
profiling, autoimmune disease, genetic
disease, molecular infectious disease, and
biomarker monitoring |
|
|
Open architecture platform allows market leading companies
to provide compatible kits and software |
 |
 |
|
Bindi technology is experiencing rapid adoption across many
segments of the life sciences. See the growing bibliography
list of publications in the key areas of
biomarker
Profiling, Molecular and Immunodiagnostics,
Pathogen testing, and Biodefense/Environmental
and Healthcare domains. |
|
|
|
|
|
